London, England, United Kingdom In 2007 was created Satya Capital, which is appeared as VC. The main department of described VC is located in the London. The company was established in Europe in United Kingdom.
The overall number of key employees were 2.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Nigeria. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight iSON Xperiences, Cellulant, Hygeia Group. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Health Care, Internet.
Deals in the range of more than 100 millions dollars are the general things for fund. Opposing the other organizations, this Satya Capital works on 1 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2016.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Satya Capital, startups are often financed by North Bridge Venture Partners & Growth Equity, Liberty Global Ventures, HSBC. The meaningful sponsors for the fund in investment in the same round are The Rise Fund, Sofina, SES S.A.. In the next rounds fund is usually obtained by Swiss RE, Sofina, SES S.A..
Related Funds
| Fund Name | Location |
| Asatsu DK | Hokkaido Prefecture, Japan, Sapporo |
| Cambia Health Solutions | Oregon, Portland, United States |
| CNBC | Englewood Cliffs, New Jersey, United States |
| Cohen & Steers Inc. | New York, New York, United States |
| Javelin Venture Partners | California, San Francisco, United States |
| JHC Ventures | - |
| Kensington Partners | Australia, Perth, Western Australia |
| MF Private Capital | Boston, Massachusetts, United States |
| Mitsubishi Corporation | Chiyoda, Japan |
| octopus | Arizona, Scottsdale, United States |
| SEGNEL Ventures | Central, Central Region, Singapore |
| Sino Pacific Capital | China, Guangdong, Shenzhen |
| Timken Foundation of Canton | - |
| TPG Biotech | California, San Francisco, United States |
| WP Global Partners | Chicago, Illinois, United States |
| WTT Investment | - |
| Xingfan Touzi | China, Ningbo, Zhejiang |
| Xinyu Xinchengzhang | China, Guangdong, Jiangxi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellulant | $47M | 14 May 2018 | Nairobi, Nairobi, Kenya |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cellulant | $47M | 14 May 2018 | Nairobi, Nairobi, Kenya |
